Skip to main content

Table 3 Characteristics of the subjects in both groups after crossover and continuation of drug for further 8 weeks

From: LDL-cholesterol lowering effect of a generic product of simvastatin compared to simvastatin (Zocor™) in Thai hypercholesterolemic subjects – a randomized crossover study, the first report from Thailand

Parameters mean ± standard deviation (90 % confidence interval) P-value
  1st group (N = 21) 2nd group (N = 16)  
Total cholesterol (mg/dL) 200.30 ± 36.86 182.40 ± 17.24 NS
  (187.07–213.53) (175.31–189.49)  
HDL (mg/dL) 47.40 ± 9.64 49.40 ± 10.38 NS
  (43.94–50.86) (45.13–53.67)  
Triglyceride (mg/dL) 142.40 ± 62.54 127.40 ± 58.40 NS
  (119.95–164.85) (103.38–151.42)  
LDL (mg/dL) 124.40 ± 31.70 107.50 ± 14.65 NS
  (113.02–135.78) (101.48–113.52)  
SGOT (U/L) 25.10 ± 7.96 23.90 ± 9.50 NS
  (22.24–27.96) (19.99–27.81)  
SGPT (U/L) 37.60 ± 22.32 30.60 ± 21.79 NS
  (29.59–45.61) (21.64–39.56)  
CPK (U/L) 106.20 ± 42.49 118.40 ± 42.35 NS
  (90.95–121.45) (100.98–135.82)